19-41007013-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000767.5(CYP2B6):āc.593T>Cā(p.Met198Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000199 in 1,614,036 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as drug response (no stars).
Frequency
Genomes: š 0.00061 ( 0 hom., cov: 31)
Exomes š: 0.00016 ( 3 hom. )
Consequence
CYP2B6
NM_000767.5 missense
NM_000767.5 missense
Scores
1
3
15
Clinical Significance
Conservation
PhyloP100: 5.76
Genes affected
CYP2B6 (HGNC:2615): (cytochrome P450 family 2 subfamily B member 6) This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.027706802).
BS2
High AC in GnomAd4 at 93 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP2B6 | NM_000767.5 | c.593T>C | p.Met198Thr | missense_variant | 4/9 | ENST00000324071.10 | NP_000758.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP2B6 | ENST00000324071.10 | c.593T>C | p.Met198Thr | missense_variant | 4/9 | 1 | NM_000767.5 | ENSP00000324648 | P1 | |
CYP2B6 | ENST00000593831.1 | c.256+2567T>C | intron_variant | 2 | ENSP00000470582 | |||||
CYP2B6 | ENST00000594187.1 | n.177T>C | non_coding_transcript_exon_variant | 2/2 | 5 | |||||
CYP2B6 | ENST00000598834.2 | c.497T>C | p.Met166Thr | missense_variant, NMD_transcript_variant | 4/10 | 5 | ENSP00000496294 |
Frequencies
GnomAD3 genomes AF: 0.000605 AC: 92AN: 152094Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
92
AN:
152094
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000310 AC: 78AN: 251454Hom.: 1 AF XY: 0.000309 AC XY: 42AN XY: 135900
GnomAD3 exomes
AF:
AC:
78
AN:
251454
Hom.:
AF XY:
AC XY:
42
AN XY:
135900
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000157 AC: 229AN: 1461824Hom.: 3 Cov.: 33 AF XY: 0.000164 AC XY: 119AN XY: 727212
GnomAD4 exome
AF:
AC:
229
AN:
1461824
Hom.:
Cov.:
33
AF XY:
AC XY:
119
AN XY:
727212
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000611 AC: 93AN: 152212Hom.: 0 Cov.: 31 AF XY: 0.000712 AC XY: 53AN XY: 74418
GnomAD4 genome
AF:
AC:
93
AN:
152212
Hom.:
Cov.:
31
AF XY:
AC XY:
53
AN XY:
74418
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
40
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: drug response
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Efavirenz response Other:1
drug response, no assertion criteria provided | research | Institute of Microbiology; University Hospital and Univeristy of Lausanne | Jan 01, 2006 | - This variant was associated with very high efavirenz plasma levels in a HIV+individual |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
MutationTaster
Benign
D;N
PrimateAI
Benign
T
PROVEAN
Uncertain
.;D
REVEL
Benign
Sift
Uncertain
.;D
Sift4G
Pathogenic
.;D
Polyphen
B;B
Vest4
0.13
MVP
0.30
MPC
0.074
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at